Annual Short Term Debt
$9.88 M
+$7.62 M+338.20%
December 31, 2023
Summary
- As of February 7, 2025, IPHA annual short term debt is $9.88 million, with the most recent change of +$7.62 million (+338.20%) on December 31, 2023.
- During the last 3 years, IPHA annual short term debt has risen by +$7.24 million (+274.93%).
- IPHA annual short term debt is now -71.63% below its all-time high of $34.81 million, reached on December 31, 2021.
Performance
IPHA Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$9.57 M
-$306.90 K-3.11%
June 30, 2024
Summary
- As of February 7, 2025, IPHA quarterly short term debt is $9.57 million, with the most recent change of -$306.90 thousand (-3.11%) on June 30, 2024.
- Over the past year, IPHA quarterly short term debt has increased by +$3.77 million (+65.08%).
- IPHA quarterly short term debt is now -72.51% below its all-time high of $34.81 million, reached on December 31, 2021.
Performance
IPHA Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
IPHA Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +338.2% | +65.1% |
| 3 y3 years | +274.9% | +65.1% |
| 5 y5 years | +541.1% | +65.1% |
IPHA Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -71.6% | +338.2% | -72.5% | +324.6% |
| 5 y | 5-year | -71.6% | +338.2% | -72.5% | +324.6% |
| alltime | all time | -71.6% | +1693.0% | -72.5% | +1747.0% |
Innate Pharma SA Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $9.57 M(-3.1%) |
| Dec 2023 | $9.88 M(+338.2%) | $9.88 M(+70.4%) |
| Jun 2023 | - | $5.80 M(+157.2%) |
| Dec 2022 | $2.25 M(-93.5%) | $2.25 M(-93.0%) |
| Jun 2022 | - | $32.23 M(-7.4%) |
| Dec 2021 | $34.81 M(+1221.4%) | $34.81 M(+1350.4%) |
| Jun 2021 | - | $2.40 M(-8.9%) |
| Dec 2020 | $2.63 M(+10.4%) | $2.63 M(+15.1%) |
| Jun 2020 | - | $2.29 M(-4.1%) |
| Dec 2019 | $2.39 M(+54.9%) | $2.39 M(+21.9%) |
| Jun 2019 | - | $1.96 M(+27.1%) |
| Dec 2018 | $1.54 M(-4.4%) | $1.54 M(-1.7%) |
| Jun 2018 | - | $1.57 M(-2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $1.61 M(+20.6%) | $1.61 M(+17.2%) |
| Jun 2017 | - | $1.38 M(+2.9%) |
| Dec 2016 | $1.34 M(+96.5%) | $1.34 M(+41.0%) |
| Jun 2016 | - | $947.70 K(+39.4%) |
| Dec 2015 | $680.00 K(+23.4%) | $680.00 K(+31.2%) |
| Jun 2015 | - | $518.20 K(-5.9%) |
| Dec 2014 | $550.90 K(-34.9%) | $550.90 K(-9.0%) |
| Jun 2014 | - | $605.70 K(-28.4%) |
| Dec 2013 | $846.50 K(-45.7%) | $846.50 K(-44.1%) |
| Jun 2013 | - | $1.51 M(-2.9%) |
| Dec 2012 | $1.56 M(-47.1%) | $1.56 M(-47.1%) |
| Dec 2011 | $2.94 M(-66.8%) | $2.94 M(-66.8%) |
| Dec 2010 | $8.86 M | $8.86 M |
FAQ
- What is Innate Pharma SA annual short term debt?
- What is the all time high annual short term debt for Innate Pharma SA?
- What is Innate Pharma SA annual short term debt year-on-year change?
- What is Innate Pharma SA quarterly short term debt?
- What is the all time high quarterly short term debt for Innate Pharma SA?
- What is Innate Pharma SA quarterly short term debt year-on-year change?
What is Innate Pharma SA annual short term debt?
The current annual short term debt of IPHA is $9.88 M
What is the all time high annual short term debt for Innate Pharma SA?
Innate Pharma SA all-time high annual short term debt is $34.81 M
What is Innate Pharma SA annual short term debt year-on-year change?
Over the past year, IPHA annual short term debt has changed by +$7.62 M (+338.20%)
What is Innate Pharma SA quarterly short term debt?
The current quarterly short term debt of IPHA is $9.57 M
What is the all time high quarterly short term debt for Innate Pharma SA?
Innate Pharma SA all-time high quarterly short term debt is $34.81 M
What is Innate Pharma SA quarterly short term debt year-on-year change?
Over the past year, IPHA quarterly short term debt has changed by +$3.77 M (+65.08%)